Indian Adviser Urges More Attention to Gender-Specific Drugs
This article was originally published in PharmAsia News
Executive Summary
An adviser at India's National Institute of Immunology says the country should place more emphasis on the differences between drugs for males and those for females. N.K. Ganguly said the country currently produces drugs focused on the needs of men while ignoring the needs of women even though the needs of each are quite different. India has developed about 30 life-saving drugs in the past few years, Ganguly said, but many are neither compatible nor affordable for Indian women. He urged drug makers to consider the changing needs of the country. (Click here for more
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.